These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

894 related items for PubMed ID: 10624398

  • 1. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 2. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER, Klugherz B, Goldman R, Kimmel SE, Wade M, Sehgal CM.
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [Abstract] [Full Text] [Related]

  • 3. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [Abstract] [Full Text] [Related]

  • 4. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E, Sardina M, Prior M, De Marchi S, Zannoni M, Bianchini C.
    Eur Rev Med Pharmacol Sci; 1998 Oct; 2(2):53-9. PubMed ID: 10229559
    [Abstract] [Full Text] [Related]

  • 5. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB, Lotina SI, Kostić DM, Cinara II, Cvetković SD, Stojanov PL, Velimirović DB, Marković MM, Pejkić SA, Vukotić AM.
    Srp Arh Celok Lek; 1997 Oct; 125(1-2):24-35. PubMed ID: 17974352
    [Abstract] [Full Text] [Related]

  • 6. [Use of prostacyclin in the treatment of patients with chronic occlusion of the peripheral arteries (stage IV)].
    Maksimović Z, Djukić V, Lotina S, Mujović V, Radak Dj.
    Srp Arh Celok Lek; 1989 Oct; 117(1-2):17-25. PubMed ID: 2508243
    [Abstract] [Full Text] [Related]

  • 7. [Surgery of abdominal aorta with horseshoe kidney].
    Lotina SL, Davidović LB, Kostić DM, Velimirović DV, Petrović PLj, Perisić-Savić MV, KovacevićN S.
    Srp Arh Celok Lek; 1997 Oct; 125(1-2):36-44. PubMed ID: 17974353
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia. A placebo controlled multicenter study. Norwegian Pentoxifylline Multicenter Trial Group.
    Int Angiol; 1996 Mar; 15(1):75-80. PubMed ID: 8739541
    [Abstract] [Full Text] [Related]

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 10. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S, Jenelten R, Wagner S, Allmann J, Banyai M, Koppensteiner R.
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [Abstract] [Full Text] [Related]

  • 11. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A, Tascino C, Costa F.
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 13. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P, Videcnik V.
    Wien Klin Wochenschr; 1999 Jan 15; 111(1):21-5. PubMed ID: 10067266
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM, Ardita G, Giani L, Mugno F, Stevenazzi F, Mazzone A.
    Minerva Cardioangiol; 2006 Jun 15; 54(3):377-81. PubMed ID: 16733512
    [Abstract] [Full Text] [Related]

  • 18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Jun 15; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 19. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G, Poggiali C, Calacoci S, Marino N, Rosselli A.
    Recenti Prog Med; 1989 Apr 15; 80(4):204-7. PubMed ID: 2762658
    [Abstract] [Full Text] [Related]

  • 20. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
    Cappelli R, Bicchi M, Arrigucci S, Boschi S, Guerrini M, Forconi S.
    Minerva Cardioangiol; 1999 Mar 15; 47(3):81-8. PubMed ID: 10389449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.